OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
Ensoma
We are an in vivo hematopoietic stem cell (HSC) engineering company.
In vivo hematopoietic stem cells for Oncology and Genetic Diseases
Boston, MA, United States
WebsiteEpigenic Therapeutics
Dedicated to developing next-generation gene modulation therapy utilizing regulation of the epigenetic genome for a variety of human diseases
Targeted epigenetic therapeutics via CRISPR-Cas components and LNPs across therapeutic areas Shanghai, China
WebsiteEpitopea
We believe better cancer therapies are needed to transform people's lives. We are developing accessible off-the-shelf cancer RNA immunotherapies that will deliver durable benefits.
Shared neoantigen-based RNA vaccines for Oncology Montréal, QC, Canada WebsiteErVimmune
ErVimmune develops cancer vaccines and T cell-based therapies as breakthrough immunotherapies to address unmet medical needs in cold tumors. We are dedicated to discovering more accurate non-mutated tumor epitopes that are shared across patients and indications. Supported by a proprietary, AI-driven target discovery platform, we focus on non-conventional antigens derived from human endogenous retroviruses (HERVs) as targets that we validate by proteomics and immunology assays. From bioinformatics to proteomics!
Cancer vaccines and T cell-based therapies targeting HERV-derived antigens, for Cancer Immunotherapy Lyon, France WebsiteESH
The European School of Haematology (ESH) is a not-for-profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Haematology.
Hematology; Cancer; Oncology Paris, France WebsiteESID (European Society for Immunodeficiencies)
The European Society for immunodeficiencies (ESID) is a non for profit association that was created in 1994. ESID has been striving to improve the knowledge in the field of Primary Immunodeficiency (PID) by encouraging research, developing educational programs and fostering cooperation among all those involved in the diagnosis, treatment and management of these diseases. ESID is organized in 7 working parties – Inborn Errors, Clinical, Education, Genetics, Registry, ESID Juniors, PID Care in Development. ESID has invested in several activities such as: · ESID Biennial Congress; · ESID Summer School; · Endorsed activities; · Awards and Grants; · ESID Registry; and · ESID Guidelines
WebsiteESMO
The European Society for Medical Oncology's (ESMO) core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up. It is to educate – doctors, cancer patients and the general public – on the best practices and latest advances in oncology. And it is to promote equal access to optimal cancer care for all patients.
Lugano, Switzerland WebsiteESO
The European School of Oncology (ESO) is an independently funded non profit organisation dedicated to quality education and training, because we believe all patients deserve equal access to competent cancer care.
Bellinzona, Switzerland WebsiteEsperantra
In Spanish: "ESPERANTRA es una organización sin fines de lucro, fundada con el propósito de contribuir en la reducción de la mortalidad por cáncer, enfermedades raras y crónicas no transmisbles en el Perú y mejorar la calidad de vida de los pacientes, abogando por la igualdad de acceso a tratamientos de calidad y cuidados innovadores. Hasta el 2005 no existía ninguna organización que representara y catalizara las necesidades de los pacientes, por tal motivo se creo ESPERANTRA. Somos la primera organización a nivel nacional que proporciona información y ayuda a través de sus diversos programas orientados al bienestar de los pacientes de todas las edades y sus familiares. MISIÓN: Informar, educar y orientar a los pacientes, familiares y población en general para lograr un diagnostico oportuno mediante programas de prevención responsable y control de la enfermedad trabajando en conjunto con los tomadores de desiciones para mejorar la calidad de vida de los pacientes del Perú con estos diagnósticos."
San Isidro (Lima), Peru WebsiteESPUM (École de santé publique)
The only French-language school in the world and the second in Canada to be accredited by the Council on Education for Public Health (CEPH), the School of Public Health of the Université de Montréal (ESPUM) is a centre of excellence and critical thinking in teaching, research and knowledge translation in all fields of public health. Drawing on knowledge derived from scientific excellence, the School offers recognized high-level training for undergraduate and graduate students.
WebsiteESTRO (European Society for Radiotherapy & Oncology)
ESTRO’s new vision statement for 2030 ‘Radiation Oncology. Optimal Health for All, Together.’ emphasizes the ambition of the Society to further reinforce radiation oncology as core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. To do so, it will actively focus on translating science and evidence into practice. It will continue to support all radiotherapy professionals in their needs of continuous professional development. The needs of a growing Society in terms of governance and leadership will actively be addressed. The Society will also increasingly embrace its role in policy, through a broadening network of partnerships with all relevant stakeholders. Without calling for a disruptive change with the past, but conscious of the challenges ahead, the ESTRO vision statement for 2030 is ambitious, expansive, inclusive and open to the future.
WebsiteEURACAN
EURACAN is a consortium of 102 European expert centres, European Patients Advocates (ePAGs) and relevant stakeholders whose goal is to improve access to care and clinical excellence for patients with Rare Adult Solid Cancers (RASCs) across the European Union and Ukraine.
WebsiteEuropean Hematology Association (EHA)
The European Hematology Association (EHA) strengthens international cooperation and access to knowledge to drive sustainable progress in hematology. Its Vision: to be the leading community to accelerate progress in hematology. Its Mission: to mobilize professionals, sharing knowledge, and connecting interests to advocate hematology in Europe and beyond.
WebsiteExelixis
We are innovating at the forefront of cancer care. Our comprehensive approach is powered by a broad array of diverse biotherapeutics and small molecule programs for the treatment of cancer exploring multiple modalities and mechanisms of action.
WebsiteFALP (Fundación Arturo López Pérez)
In Spanish: "Misión: Somos una Institución sin fines de lucro que busca otorgar acceso oportuno -en especial a las familias más vulnerables- a un tratamiento integral en un Centro Oncológico de alta especialización, en un ambiente de respeto y calidez donde los pacientes y sus familias se sientan seguros y acogidos. Aportamos al desarrollo de la oncología del país con programas de educación, prevención y detección precoz del cáncer, disponiendo de tecnologías innovadoras, desarrollando investigación avanzada y formando profesionales especializados. Visión: Queremos contribuir a que en nuestro país la condición social no sea un impedimento para recibir una atención oncológica oportuna, integral y de excelencia. Donde la docencia e investigación aporten al desarrollo de mejores tratamientos y a que las personas adquieran hábitos de vida saludables y sean activas en su cuidado, disminuyendo así el riesgo de verse afectadas por el cáncer."
Providencia (Santiago), Chile WebsiteFEHH (Fundación Española de Hematología y Hemoterapia)
In Spanish: "La Fundación Española de Hematología y Hemoterapia (FEHH) se creó en 1996 con el objetivo de captar recursos para las becas de investigación y las actividades formativas y editoriales y, reservándose la SEHH para todos los aspectos directamente relacionados con los socios y con el contenido de la especialidad. De una manera gráfica, se dice que la SEHH y la FEHH son como dos caras de una misma moneda y se actuará a través de una u otra entidad en función de los objetivos establecidos para cada actividad. En la actualidad, la FEHH se ocupa de la organización del Congreso Nacional y del desarrollo del Programa de Garantía Externa de la Calidad en Hematología, además de la formación continuada, el fondo editorial y los premios y becas."
WebsiteFHU Care
FHU CARE aims at bringing together clinicians and scientists involved in Autoimmune Diseases, Inflammatory Diseases and Cancer to favor the emergence of new paradigms : · Pathophysiology of Cancer and of Autoimmune Diseases (AID) / Inflammatory Diseases (ID) may share common or opposite mechanisms. · Treatment of Autoimmunity and treatment of Cancer are inter-related.
Autoimmune Diseases, Inflammatory Diseases and Cancer Paris, France WebsiteFILO (French Innovative Leukemia Organization)
FILO is a Cooperative Group aiming at implementing and carrying out biomedical, epidemiological, clinical, pharmacological and biological research in the field of Chronic Lymphoid Leukemia (CLL), Waldenström's Disease (MW), Acute Myeloblastic Leukemia (AML) and other pathological conditions such as Myeloproliferative Syndromes. It also endeavors to pursue educational and / or informative actions intended for medical professionals and patients.
Leukemia R&D, Training and Outreach Tours, France WebsiteFITC
In French: "La FITC (Société Française d’Immuno-Thérapie du Cancer) a été créée pour réunir au sein d’une entité unique l’ensemble des acteurs impliqués en onco-immunologie et immunothérapie du cancer et constituer ainsi une société savante témoignant de l’expertise française à l’échelle nationale et internationale sur cette nouvelle ère thérapeutique."
France WebsiteFlare Therapeutics
Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Founded on the spirit of innovation, and based on insights from the seminal work of our scientific founders, the FlareTx team has built a best-in-biotech chemistry and proteomics engine, which enables ligand discovery directly from cells. Today the company is advancing a novel pipeline with compelling emerging clinical data. Flare Therapeutics has lead programs in advanced urothelial cancer and prostate cancer, a partnership with Roche and a rich discovery pipeline and early development programs across multiple therapeutic areas.
Small-molecule inhibitors of transcription factors for treatment of solid tumors Cambridge, MA, United States WebsiteFondation ARC
In French: "Nous sommes la Fondation ARC pour la recherche sur le cancer. Pour nous, tout part d’une conviction : seule la recherche vaincra le cancer. C’est grâce aux découvertes des chercheuses et des chercheurs que nous finirons par remporter la victoire : parvenir à guérir un jour le cancer, tous les cancers."
Cancer Research Funding Villejuif, France WebsiteFondation ARCAD
In French: "Fondée en 2006 par le Pr Aimery de Gramont, et présidée par le Pr Thierry André depuis 2022, la Fondation A.R.CA.D, Aide et Recherche en CAncérologie Digestive, est l’unique fondation de recherche reconnue d’utilité publique en France dédiée exclusivement aux cancers digestifs. Nos actions se focalisent sur les patients, leurs aidants et les professionnels de santé afin d’améliorer le parcours de soin. La Fondation a pour missions de : soutenir et promouvoir la recherche clinique ainsi que des soins de qualité ; informer et aider les patients et les aidants ; sensibiliser la population ainsi que les acteurs de santé pour une prévention et un dépistage accru."
Gastrointestinal Cancers Paris, France Website